Comparison of long-term prognostic value of N-terminal-proBNP and midregional-pro-adrenomedullin in patients with acute myocardial infarction

Clinical Laboratory

Volumn 56, Issue 7-8, 2010, Pages 303-309

  Walter, Thomas ^a   Brueckmann, Martina ^a   Lang, Siegfried ^a   Sauer, Tamara ^a   Fiedler, Esther ^a   Papassotiriou, Jana ^b   Behnes, Michael ^a   Elmas, Elif ^a   Borggrefe, Martin ^a   Bertsch, Thomas ^c  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b Biotechnology Centre   (Germany)

^c Laboratory Medicine and Transfusion Medicine   (Germany)

Author keywords

Acute myocardial infarction; Adverse clinical events; MR proADM; NT proBNP; Prognostic value

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; MIDREGIONAL PRO ADRENOMEDULLIN; PROADRENOMEDULLIN; UNCLASSIFIED DRUG; ADRENOMEDULLIN; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; PEPTIDE FRAGMENT; PRO BRAIN NATRIURETIC PEPTIDE (1 76); PRO-BRAIN NATRIURETIC PEPTIDE (1-76);

ADULT; AGED; ARTICLE; CARDIOGENIC SHOCK; CLINICAL ARTICLE; CONGESTIVE HEART FAILURE; CORONARY ARTERY BYPASS GRAFT; DEATH; FEMALE; FOLLOW UP; HUMAN; MALE; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PREDICTIVE VALUE; PROGNOSIS; RECURRENT DISEASE; RESUSCITATION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SYNCOPE; AREA UNDER THE CURVE; BLOOD; BLOOD ANALYSIS; CLINICAL TRIAL; COMPARATIVE STUDY; HEART INFARCTION; HEMODYNAMICS; MIDDLE AGED; PATHOPHYSIOLOGY; PREDICTION AND FORECASTING; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC;

SYNCOPE;

ADRENOMEDULLIN; AREA UNDER CURVE; BIOLOGICAL MARKERS; BLOOD CHEMICAL ANALYSIS; FEMALE; HEMODYNAMICS; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; ROC CURVE;

EID: 77957327432     PISSN: 14336510     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Kragelund C, Gronning B, Kober L, Hildebrandt P, Steffensen R. N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease. N Engl J Med 2005;352(7):666-75. (Pubitemid 40239214)
2. Jernberg T, James S, Lindahl B, et al. Natriuretic peptides in unstable coronary artery disease. Eur Heart J 2004;25(17):1486-93. (Pubitemid 39165626)
3. Meyer B, Huelsmann M, Wexberg P et al. N-terminal pro-B-type natriuretic peptide is an independent predictor of outcome in an unselected cohort of critically ill patients. Crit Care Med 2007;35(10):2268-73. (Pubitemid 47476222)
4. Ogawa A, Seino Y, Yamashita T, Ogata K, Takano T. Difference in elevation of N-terminal pro-BNP and conventional cardiac markers between patients with ST elevation vs non-ST elevation acute coronary syndrome. Circ J 2006;70(11):1372-8. (Pubitemid 44672890)
5. Beltowski J, Jamroz A. Adrenomedullin-what do we know 10 years since its discovery? Pol J Pharmacol 2004;56(1):5-27. (Pubitemid 38515282)
6. Ishimitsu T, Ono H, Minami J, Matsuoka H. Pathophysiologic and therapeutic implications of adrenomedullin in cardiovascular disorders. Pharmacol Ther 2006;111(3):909-27. (Pubitemid 44118439)
7. Morgenthaler NG, Struck J, Alonso C, Bergmann A. Measurement of midregional proadrenomedullin in plasma with an immunoluminometric assay. Clin Chem 2005;51(10):1823-9. (Pubitemid 41368172)
8. Struck J, Tao C, Morgenthaler NG, Bergmann A. Identification of an Adrenomedullin precursor fragment in plasma of sepsis patients. Peptides 2004;25(8):1369-72. (Pubitemid 39180069)
9. Tello-Montoliu A, Marin F, Roldan V, et al. A multimarker risk stratification approach to non-ST elevation acute coronary syndrome: implications of troponin T, CRP, NT pro-BNP and fibrin D-dimer levels. J Intern Med 2007;262(6):651-8. (Pubitemid 350135197)
10. Behnes M, Papassotiriou J, Walter T, et al. Long-term prognostic value of mid-regional pro-adrenomedullin and C-terminal pro-endothelin-1 in patients with acute myocardial infarction. Clin Chem Lab Med 2008;46(2):204-11.
11. Khan SQ, Kelly D, Quinn P, Davies JE, Ng LL. Myeloperoxidase aids prognostication together with N-terminal pro-B-type natriuretic peptide in high-risk patients with acute ST elevation myocardial infarction. Heart 2007;93(7):826-31. (Pubitemid 46998982)
12. Omland T, Sabatine MS, Jablonski KA, et al. Prognostic value of B-Type natriuretic peptides in patients with stable coronary artery disease: the PEACE Trial. J Am Coll Cardiol 2007;50(3):205-14. (Pubitemid 47031568)
13. Heeschen C, Hamm CW, Mitrovic V, Lantelme NH, White HD. N-terminal pro-B-type natriuretic peptide levels for dynamic risk stratification of patients with acute coronary syndromes. Circulation 2004;110(20):3206-12. (Pubitemid 39525067)
14. Omland T, Persson A, Ng L, et al. N-terminal pro-B-type natriuretic peptide and long-term mortality in acute coronary syndromes. Circulation 2002;106(23):2913-8. (Pubitemid 35424741)
15. Richards AM, Nicholls MG, Yandle TG, et al. Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction. Circulation 1998;97(19):1921-9.
16. Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983;148(3):839-43. (Pubitemid 13033817)
17. Palazzuoli A, Deckers J, Calabro A, et al. Brain natriuretic peptide and other risk markers for outcome assessment in patients with non-ST-elevation coronary syndromes and preserved systolic function. Am J Cardiol 2006;98(10):1322-8. (Pubitemid 44666636)
18. Omland T, Aakvaag A, Bonarjee VV, et al. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide. Circulation 1996;93(11):1963-9.
19. Talwar S, Squire IB, Downie PF, et al. Profile of plasma N-terminal proBNP following acute myocardial infarction; correlation with left ventricular systolic dysfunction. Eur Heart J 2000;21(18):1514-21.
20. Sabatine MS, Morrow DA, de Lemos JA, et al. Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide. Circulation 2002;105(15):1760-3. (Pubitemid 34408881)
21. Talwar S, Squire IB, Downie PF, Davies JE, Ng LL. Plasma N terminal pro-brain natriuretic peptide and cardiotrophin 1 are raised in unstable angina. Heart 2000; 84(4):421-4.
22. Marumoto K, Hamada M, Hiwada K. Increased secretion of atrial and brain natriuretic peptides during acute myocardial ischaemia induced by dynamic exercise in patients with angina pectoris. Clin Sci (Lond) 1995;88(5):551-6.
23. Bibbins-Domingo K, Ansari M, Schiller NB, Massie B, Whooley MA. B-type natriuretic peptide and ischemia in patients with stable coronary disease: data from the Heart and Soul study. Circulation 2003;108(24):2987-92. (Pubitemid 37553567)
24. Tateishi J, Masutani M, Ohyanagi M, Iwasaki T. Transient increase in plasma brain (B-type) natriuretic peptide after percutaneous transluminal coronary angioplasty. Clin Cardiol 2000;23(10):776-80.
25. D'Souza SP, Davis M, Baxter GF. Autocrine and paracrine actions of natriuretic peptides in the heart. Pharmacol Ther 2004;101(2):113-29 (Pubitemid 38167564)